InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by van Houte Hans, Chief Financial Officer. Director active across 1 company, notably Nurix Therapeutics, Inc.. In total, 39 filings have been recorded. Split: 0 buy · 16 sells. Total volume traded: €1.7m. History available since 30 April 2022. The latest transaction was filed on 4 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to van Houte Hans
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
1,794 shares@ US$23.89110.0018% mcap2.2% of flowCommon StockSEC:0001817217-26-000012:0
2,967 shares@ US$24.64740.0030% mcap3.7% of flowCommon StockSEC:0001817217-26-000012:1
3,750 shares0Common StockSEC:0001817217-26-000010:0
2,858 shares0Common StockSEC:0001817217-26-000010:1
3,572 shares0Common StockSEC:0001817217-26-000010:2
2,845 shares@ US$23.38280.0027% mcap3.6% of flowCommon StockSEC:0001817217-26-000010:3
2,000 shares0Common StockSEC:0001817217-26-000006:0
3,750 shares0Common StockSEC:0001817217-26-000006:1
2,858 shares0Common StockSEC:0001817217-26-000006:2
2,388 shares@ US$16.64530.0016% mcap2.4% of flowCommon StockSEC:0001817217-26-000006:3
2,887 shares0Common StockSEC:0001817217-26-000002:0
6,284 shares@ US$12.56074.4% of flowCommon StockSEC:0001817217-25-000005:0
2,886 shares0Common StockSEC:0001817217-25-000003:0
5,402 shares@ US$11.03253.5% of flowCommon StockSEC:0001549595-25-000103:0
2,886 shares0Common StockSEC:0001549595-25-000101:0
6,198 shares@ US$11.33314.5% of flowCommon StockSEC:0001549595-25-000063:0
2,886 shares0Common StockSEC:0001549595-25-000059:0
5,125 shares@ US$14.39945.1% of flowCommon StockSEC:0001549595-25-000037:0
2,886 shares0Common StockSEC:0001549595-25-000020:0
3,546 shares@ US$24.27625.7% of flowCommon StockSEC:0001549595-24-000153:0
2,886 shares0Common StockSEC:0001549595-24-000148:0
20,000 shares@ US$25.218532.4% of flowCommon StockSEC:0001549595-24-000112:0
3,377 shares@ US$21.42554.8% of flowCommon StockSEC:0001549595-24-000110:0
2,886 shares0Common StockSEC:0001549595-24-000104:0
20,000 shares@ US$20.010826.8% of flowCommon StockSEC:0001549595-24-000088:0
25 of 39 declarations
About van Houte Hans
van Houte Hans is Chief Financial Officer at Nurix Therapeutics, Inc. The declarant has 33 filings in total, and, across the sampled recent filings from 2022-05-03 to 2026-04-30, the cumulative sell volume is EUR 1496543 and the modal transaction nature is option exercise.
